197 related articles for article (PubMed ID: 32742192)
1. Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors.
Kim E; Kim M; So K; Park YS; Woo CG; Hyun SH
Cancer Cell Int; 2020; 20():345. PubMed ID: 32742192
[TBL] [Abstract][Full Text] [Related]
2. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
3. Landscape of genetic variants in sporadic meningiomas captured with clinical genomics.
Leclair NK; Shen E; Wu Q; Wolansky L; Becker K; Li L; Bulsara KR
Acta Neurochir (Wien); 2022 Sep; 164(9):2491-2503. PubMed ID: 35881312
[TBL] [Abstract][Full Text] [Related]
4. Specific gene expression signatures of low grade meningiomas.
Tsitsikov EN; Hameed S; Tavakol SA; Stephens TM; Tsytsykova AV; Garman L; Bi WL; Dunn IF
Front Oncol; 2023; 13():1126550. PubMed ID: 36937440
[TBL] [Abstract][Full Text] [Related]
5. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
[TBL] [Abstract][Full Text] [Related]
6. Genomic analysis of synchronous intracranial meningiomas with different histological grades.
Chowdhury T; Yoo Y; Seo Y; Dho YS; Kim S; Choi A; Choi M; Park SH; Park CK; Lee SH; Lee JY
J Neurooncol; 2018 May; 138(1):41-48. PubMed ID: 29423538
[TBL] [Abstract][Full Text] [Related]
7. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1.
Michelhaugh SK; Guastella AR; Varadarajan K; Klinger NV; Parajuli P; Ahmad A; Sethi S; Aboukameel A; Kiousis S; Zitron IM; Ebrahim SA; Polin LA; Sarkar FH; Bollig-Fischer A; Mittal S
J Transl Med; 2015 Jul; 13():227. PubMed ID: 26174772
[TBL] [Abstract][Full Text] [Related]
8. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
Brastianos PK; Horowitz PM; Santagata S; Jones RT; McKenna A; Getz G; Ligon KL; Palescandolo E; Van Hummelen P; Ducar MD; Raza A; Sunkavalli A; Macconaill LE; Stemmer-Rachamimov AO; Louis DN; Hahn WC; Dunn IF; Beroukhim R
Nat Genet; 2013 Mar; 45(3):285-9. PubMed ID: 23334667
[TBL] [Abstract][Full Text] [Related]
9. Genomic profile of human meningioma cell lines.
Mei Y; Bi WL; Greenwald NF; Agar NY; Beroukhim R; Dunn GP; Dunn IF
PLoS One; 2017; 12(5):e0178322. PubMed ID: 28552950
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S
Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201
[TBL] [Abstract][Full Text] [Related]
11. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.
Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K
Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701
[TBL] [Abstract][Full Text] [Related]
12. High-grade meningiomas: biology and implications.
Bi WL; Prabhu VC; Dunn IF
Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
[TBL] [Abstract][Full Text] [Related]
13. Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas.
González-Tablas M; Prieto C; Arandia D; Jara-Acevedo M; Otero Á; Pascual D; Ruíz L; Álvarez-Twose I; García-Montero AC; Orfao A; Tabernero MD
Front Oncol; 2021; 11():740782. PubMed ID: 34868937
[TBL] [Abstract][Full Text] [Related]
14. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
Peyre M; Stemmer-Rachamimov A; Clermont-Taranchon E; Quentin S; El-Taraya N; Walczak C; Volk A; Niwa-Kawakita M; Karboul N; Giovannini M; Kalamarides M
Oncogene; 2013 Sep; 32(36):4264-72. PubMed ID: 23045274
[TBL] [Abstract][Full Text] [Related]
15. SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.
Boetto J; Bielle F; Sanson M; Peyre M; Kalamarides M
Neuro Oncol; 2017 Mar; 19(3):345-351. PubMed ID: 28082415
[TBL] [Abstract][Full Text] [Related]
16. Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.
Surace EI; Lusis E; Murakami Y; Scheithauer BW; Perry A; Gutmann DH
J Neuropathol Exp Neurol; 2004 Oct; 63(10):1015-27. PubMed ID: 15535129
[TBL] [Abstract][Full Text] [Related]
17. Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma.
Zhang H; Qi L; Du Y; Huang LF; Braun FK; Kogiso M; Zhao Y; Li C; Lindsay H; Zhao S; Injac SG; Baxter PA; Su JM; Stephan C; Keller C; Heck KA; Harmanci A; Harmanci AO; Yang J; Klisch TJ; Li XN; Patel AJ
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517016
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
19. Clinical potential of meningioma genomic insights: a practical review for neurosurgeons.
Karsy M; Azab MA; Abou-Al-Shaar H; Guan J; Eli I; Jensen RL; Ormond DR
Neurosurg Focus; 2018 Jun; 44(6):E10. PubMed ID: 29852774
[TBL] [Abstract][Full Text] [Related]
20. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]